Holen Sie sich die Stockscreener-App
1.395
0.36%
0.005
Autonomix Medical Inc Aktie (AMIX) Neueste Nachrichten
What analysts say about Autonomix Medical Inc. stockFree Stock Chart Pattern Guide - Autocar Professional
Autonomix Medical Inc. Stock Analysis and ForecastUnmatched market performance - Autocar Professional
Autonomix Medical Announces exercise of warrants for $2.5M gross proceeds - MSN
Is Autonomix Medical Inc. a good long term investmentAccelerated investment success - jammulinksnews.com
Autonomix announces exercise of warrants for $2.5M gross proceeds - TipRanks
Autonomix Medical Plunges 22.95% Intraday—Is This a Sell-Off or a Buy Opportunity? - AInvest
Autonomix Medical, Inc. Exercise of Warrants for $2.5 Million Gross Proceeds - GlobeNewswire
Autonomix Medical, Inc. Participates in the Virtual Investor 'What’s Your Story” Summer Spotlight On-Demand Conference - The Manila Times
Autonomix Medical raises $2.5 million through warrant exercise deal By Investing.com - Investing.com Nigeria
Autonomix Medical, Inc. Participates in the Virtual - GlobeNewswire
Autonomix Medical CEO Shares Exclusive Insights on Revolutionary Nervous System Technology Future - Stock Titan
Medical Device Pioneer Autonomix Secures $2.5M Fresh Capital as Investors Exercise Warrants - Stock Titan
What drives Autonomix Medical Inc. stock priceOutstanding investment returns - jammulinksnews.com
Autonomix Medical, Inc. Granted New U.S. Patent to Advance - GlobeNewswire
Autonomix Medical Inc. Skyrocketing: Is This the Game Changer? - StocksToTrade
Autonomix Medical Shares Jump 13% Following Smart Torquer Patent Approval - MSN
Autonomix Medical's Volatility Shocks Markets: Can This 26% Intraday Surge Sustain Momentum? - AInvest
Autonomix Medical stock gains after securing smart torquer patent - Investing.com
Autonomix Medical stock gains after securing smart torquer patent By Investing.com - Investing.com UK
Autonomix granted new U.S. patent on smart torquer device - TipRanks
Autonomix receives patent for smart torquer device in vascular procedures - Investing.com India
Autonomix Medical, Inc. Strengthens Patent Portfolio with Issuance of U.S. Patent No. 12,295,646 for Smart Torquer Device in Nerve-Sensing Technology - Nasdaq
Patent Win: Autonomix Medical's New Nerve-Targeting Tech Could Transform Multi-Billion Dollar Treatment Market - Stock Titan
Why Autonomix Medical Inc. stock attracts strong analyst attentionFree Trading Group - Newser
What makes Autonomix Medical Inc. stock price move sharplyTop Rated Trade Entries - Newser
How Autonomix Medical Inc. stock performs during market volatilityFree Stock Market Swing Trading Strategies - Newser
Autonomix releases next CEO Corner segment - MSN
Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment - GlobeNewswire
Autonomix Medical CEO Details Next Phase of Breakthrough Nerve Treatment Trials in New Update - Stock Titan
Autonomix Medical, Inc. Treats First Patient in Follow-On - GlobeNewswire
Autonomix Medical Expands Revolutionary Cancer Pain Treatment to New Indications, Doubles Market Potential - Stock Titan
Unraveling the 60.8% Spike in Autonomix Medical: What’s Behind the Surge? - AInvest
Autonomix Medical's 60% Surge: A Technical Mystery Unveiled - AInvest
USPTO Issuance Sends Micro Cap Soaring - The Globe and Mail
Autonomix (AMIX) Secures New Patent for Neurological Treatment S - GuruFocus
Autonomix (AMIX) Secures New Patent for Neurological Treatment Systems | AMIX Stock News - GuruFocus
Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology - The Manila Times
Citadel Advisors LLC Makes New $180,000 Investment in Autonomix Medical, Inc. (NASDAQ:AMIX) - Defense World
Autonomix set to expand cancer pain treatment trial - Investing.com India
Autonomix set to expand cancer pain treatment trial By Investing.com - Investing.com South Africa
Autonomix granted approval to expand PoC human clinical trial - TipRanks
Autonomix (AMIX) Gains Approval for New Clinical Trial Phase in Uzbekistan | AMIX Stock News - GuruFocus
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):